Sunvozertinib Clinical Trials
5 recruitingDrug
Phase 24Phase 13
Showing 1–5 of 5 trials
Recruiting
Phase 2
Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
MutationLung Cancer Stage III
Sun Yat-sen University120 enrolled1 locationNCT06563999
Recruiting
Phase 1
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
Dizal Pharmaceuticals140 enrolled5 locationsNCT06905197
Recruiting
Phase 1Phase 2
Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
Dizal (Jiangsu) Pharmaceutical Co., Ltd.200 enrolled4 locationsNCT07079475
Recruiting
Phase 2
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
NSCLC
Tang-Du Hospital27 enrolled3 locationsNCT06864624
Recruiting
Phase 1Phase 2
Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II
Non-small Cell Lung Cancer
Sichuan University40 enrolled1 locationNCT06195189